Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Leerink Partners is a leading independent investment bank specializing exclusively in the healthcare and life sciences sectors. The firm provides a comprehensive range of financial services, including equity research, corporate advisory, M&A, and capital markets solutions for biopharma, medical technology, and healthcare services companies. Originally founded in 1995 as Leerink Swann, the firm operated as SVB Leerink and SVB Securities under SVB Financial Group before returning to independence through a management buyout in 2023. Leerink Partners is widely recognized for its deep industry expertise and its flagship Global Healthcare Conference, which is a premier event for healthcare investors and innovators.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Leerink Global Partners.